Market
Scenario
Molecular
modeling has become a valuable and essential tool in the medicinal chemistry
for the drug design process. It describes generation, manipulation or
representation of three-dimensional structures of molecules and their
associated physic-chemical properties. The method is used in drug design,
computational biology, computational chemistry, and materials science. It
involves wide range of computerized techniques based on theoretical chemistry
methods and experimental data to analyze the biological and molecular property.
The major
driving factor for the market are increasing investment of biotechnology and
pharmaceutical industries in R&D, increasing prevalence of different
diseases, and rising need for the better drug treatments. According to the
World Health Organization (WHO), chronic diseases, such as heart disease,
respiratory diseases, cancer, stroke, and diabetes are the leading cause of
mortality across the globe, which represents about 60% of all deaths.
Additionally, 80% of the chronic disease deaths occur in low and middle income
countries. Moreover, technological advancements, growth in the biology and
biosimilars markets, increasing need for the cost effective treatment, and
increasing government support for research & development expected to fuel
the market growth during the forecast period. However, high cost of the
research & development may hamper the market growth during the
corresponding period.
The
global molecular modelling market is expected to grow at a CAGR of ~ 15.4 %
during the forecast period 2017-2023.
Segmentations
The global molecular modelling market has been segmented on the basis of approach, application, products, and end user.
The global molecular modelling market has been segmented on the basis of approach, application, products, and end user.
On the
basis of approach, the market is segmented into molecular mechanics approach,
and quantum chemistry approach.
On the
basis of product, the market is segmented into instruments, reagents, kits, and
others.
On the
basis of application, the market is segmented into drug development, drug discovery,
and other application. The drug discovery is further segmented into direct drug
design, indirect drug design, and molecular mimicry. The direct drug design is
sub-segmented into lead identification, target identification, and others. The
indirect drug design is sub-segmented into pharmacophore, quantitative
structure-activity relationships (QSAR), and others.
On the
basis of end user, the market is segmented into pharmaceutical &
biotechnological companies, research organizations, and others.
Opportunity:
Countries
situated near the equator have become the budding ground for many chronic
diseases such as chagas, dengue, leprosy, and rabies due to problematic
climactic conditions forcing these countries to employ the latest advancements
into their system. Governments of developing countries have initiated education
programs and projects such as the Janala Project in Bangladesh, ProjectABC in
Nigeria, Tostan in Senegal, Yoza in South Africa, and BridgeIT in Tanzania, and
others to create awareness regarding the conditions and healthcare IT tools.
Regional
Analysis
The
Americas dominates the global molecular modelling market owing to
well-developed technology, increasing prevalence of the people suffering from
cardiovascular diseases, and increasing government support for research &
development. Furthermore, high healthcare expenditure and increasing R&D activities
have fuelled the growth of the market in this region.
Europe
holds the second position in the global molecular modelling market, which is
followed by Asia Pacific. It is expected that the government support for
research & development and availability of funds for research will drive
the market. Asia Pacific is the fastest growing molecular modelling market due
to the presence of rapidly growing economy, developing healthcare technology,
increasing healthcare expenditure, and huge patient pool.
On the
other hand, the Middle East & Africa holds the least share of the market
due to limited availability of medical facilities, less availability of funds,
and poor political conditions in Africa.
Major Key
Players
Some of
key the players in the market are Fisher Scientific Company LLC. (US), Indigo
Instruments (US), Simulation Plus (US), Certara, L.P. (US), Dassault Systèmes
(France), Advanced Chemistry Development (Canada), Schrödinger, LLC (US),
Genedata AG (Switzerland), Chemical Computing Group ULC (Canada), Physiomics
PLC (UK), and Entelos, Inc. (US).
Detailed
Table of Contents:
1 Report
Prologue
2 Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size
Estimation
13 MRFR
Conclusion
13.1 Key
Findings
13.1.1
From CEO’s View Point
13.1.2
Unmet Needs Of The Market
13.2
Key Companies To Watch
13.3
Prediction Of Molecular Modelling Industry
14
Appendix
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
